Genetics of Parkinson's disease

Minerva Medica

Volumn 96, Issue 3, 2005, Pages 175-186

  Bonifati, V ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

synuclein; DJ 1; Parkin; Parkinson's disease, genetics; PINK1, LRRK2

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; NUCLEAR RECEPTOR RELATED FACTOR 1; PARKIN; PROTEIN PARK6; PROTEIN UCHL1; SYNPHILIN 1; UNCLASSIFIED DRUG;

CHROMOSOME MAP; DOPAMINERGIC NERVE CELL; FAMILIAL DISEASE; GENE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LRRK2 GENE; MOLECULAR GENETICS; PARKINSON DISEASE; PINK1 GENE; RARE DISEASE; REVIEW; VALIDATION PROCESS;

ALPHA-SYNUCLEIN; CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ONCOGENE PROTEINS; PARKINSON DISEASE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; UBIQUITIN-PROTEIN LIGASES;

EID: 27844578650     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044-53.
2. Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 1998;339:1130-43.
3. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003;302:819-22.
4. Bonifati V, Oostra BA, Heutink P. Unraveling the pathogenesis of Parkinson's disease - the contribution of monogenic forms. Cell Mol Life Sci 2004;61:1729-50.
5. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-7.
6. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al. Alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
7. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998;18:106-8.
8. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I et al. The new mutation, E46K, of alpha-synuclein causes parkinson and Lewy body dementia. Ann Neurol 2004;55:164-73.
9. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004;55:174-9.
10. Ibanez P, Bonnet AM, Debarges B, Lohmann E, Tison F, Pollak P et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004;364:1169-71.
11. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004;364:1167-9.
12. Spillantini MG, Goedert M. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 2000;920:16-27.
13. Zoghbi HY, Botas J. Mouse and fly models of neurodegeneration. Trends Genet 2002;18:463-71.
14. Pals P, Lincoln S, Manning J, Heckman M, Skipper L, Hulihan M et al. alpha-Synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol 2004;56:591-5.
15. Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2001;2:492-501.
16. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002;416:507-11.
17. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004;305:1292-5.
18. Dawson TM, Dawson VL. Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest 2003;111:145-51.
19. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003;39:889-909.
20. Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 2001;294:1346-9.
21. Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002;51:296-301.
22. Zimprich A, Muller-Myhsok B, Farrer M, Leitner P, Sharma M, Hulihan M et al. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 2004;74:11-9.
23. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
24. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S et al. Mutations in LRRK2 cause autosomaldominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-7.
25. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-8.
26. Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 2000;342:1560-7.
27. Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H et al. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology 2002;58:1239-46.
28. Periquet M, Latouche M, Lohmann E, Rawal N, De Michele G, Ricard S et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 2003;126(Pt 6):1271-8.
29. Lohmann E, Periquet M, Bonifati V, Wood NW, De Michele G, Bonnet AM et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 2003;54:176-85.
30. Foroud T, Uniacke SK, Liu L, Pankratz N, Rudolph A, Halter C et al. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology 2003;60:796-801.
31. Mori H, Kondo T, Yokochi M, Matsumine H, Nakagawa-Hattori Y, Miyake T et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 1998;51:890-2.
32. Farrer M, Chan P, Chen R, Tan L, Lincoln S, Hernandez D et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001;50:293-300.
33. Sasaki S, Shirata A, Yamane K, Iwata M. Parkin-positive autosomal recessive juvenile parkinsonism with alpha-synuclein-positive inclusions. Neurology 2004;63:678-82.
34. Thobois S, Ribeiro MJ, Lohmann E, Durr A, Pollak P, Rascol O et al. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study. Arch Neurol 2003;60:713-8.
35. Scherfler C, Khan NL, Pavese N, Eunson L, Graham E, Lees AJ et al. Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism. Brain 2004;127(Pt 6):1332-42. Epub 2004 Apr 16.
36. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Mihoshima S et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000;25:302-5.
37. Feany MB, Pallanck LJ. Parkin: a multipurpose neuroprotective agent? Neuron 2003;38:13-6.
38. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 2001;293:263-9.
39. Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J et al. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 2001;7:1144-50.
40. Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L et al. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 2002;36:1007-19.
41. Yang Y, Nishimura I, Imai Y, Takahashi R, Lu B. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron 2003;37:911-24.
42. Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L et al. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 2004;304:1328-31. Epub 2004 Apr 22.
43. Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y, Gaston B et al. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci USA 2004;101:10810-4. Epub 2004 Jul 13.
44. Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E, Abeliovich A. Parkin is a component of an SCF-like ubiquitin ligase complex and protects post-mitotic neurons from kainate excitotoxicity. Neuron 2003;37:735-49.
45. Corti O, Hampe C, Koutnikova H, Darios F, Jacquier S, Prigent A et al. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet 2003;12:1427-37.
46. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA 2003;100:4078-83.
47. Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 2003;278:43628-35.
48. Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, Bohme GA et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 2003;12:2277-91.
49. Von Coelln R, Thomas B, Savitt JM, Lim KL, Sasaki M, Hess EJ et al. Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci U S A 2004;101:10744-9. Epub 2004 Jul 12.
50. van Duijn CM, Dekker MC, Bonifati V, Galjaard RJ, Houwing-Duistermaat JJ, Snijders PJ et al. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet 2001;69:629-34.
51. Bonifati V, Breedveld GJ, Squitieri F, Vanacore N, Brustenghi P, Harhangi BS et al. Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent dataset. Ann Neurol 2002;51:253-6.
52. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256-9.
53. Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW. The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann Neurol 2003;54:283-6.
54. Hague S, Rogaeva E, Hernandez D, Gulick C, Singleton A, Hanson M et al. Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann Neurol 2003;54:271-4.
55. Hedrich K, Djarmati A, Schafer N, Hering R, Wellenbrock C, Weiss PH et al. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology 2004;62:389-94.
56. Bonifati V, Oostra BA, Heutink P. Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease. J Mol Med 2004;82:163-74.
57. Martinat C, Shendelman S, Jonason A, Leete T, Beal MF, Yang L et al. Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary parkinsonism. PLoS Biol 2004;2:e327.
58. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 2004;5:213-8. Epub 2004 Jan 23.
59. Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2004;2:e362.
60. Rizzu P, Hinkle DA, Zhucareva V, Bonifati V, Severijnen L-A, Martinez D et al. DJ-1 colocalizes with tau inclusions: A link between parkinsonism and dementia. Ann Neurol 2004;55:113-8.
61. Neumann M, Muller V, Gorner K, Kretzschmar HA, Haass C, Kahle PJ. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. Acta Neuropathol (Berl) 2004;107:489-96. Epub 2004 Feb 26.
62. Valente EM, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali M et al. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 2001;68:895-900.
63. Valente EM, Brancati F, Ferraris A, Graham EA, Davis MB, Breteler MM et al. PARK6-linked parkinsonism occurs in several European families. Ann Neurol 2002;51:14-8.
64. Hatano Y, Sato K, Elibol B, Yoshino H, Yamamura Y, Bonifati V et al. PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations. Neurology 2004;63:1482-5.
65. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004;304:1158-60. Epub 2004 Apr 15.
66. Rohe CF, Montagna P, Breedveld G, Cortelli P, Oostra BA, Bonifati V. Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism. Ann Neurol 2004;56:427-31.
67. Hatano Y, Li Y, Sato K, Asakawa S, Yamamura Y, Tomiyama H et al. Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol 2004;56:424-7.
68. Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 2004;56:336-41.
69. Healy DG, Abou-Sleiman PM, Gibson JM, Ross OA, Jain S, Gandhi S et al. PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology 2004;63:1486-8.
70. Gasser T, Muller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB, Bonifati V et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18:262-5.
71. DeStefano AL, Lew MF, Golbe LI, Mark MH, Lazzarini AM, Guttman M et al. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. Am J Hum Genet 2002;70:1089-95.
72. Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH et al. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology 2003;61:1557-61.
73. Hampshire DJ, Roberts E, Crow Y, Bond J, Mubaidin A, Wriekat AL et al. Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. J Med Genet 2001;38:680-2.
74. Bertoli Avella AM, Giroud Benitez JL, Bonifati V, Alvarez Gonzalez E, Heredero Baute L, van Duijn CM et al. Suggestive linkage to chromosome 19 in a large Cuban family with late-onset Parkinson's disease. Mov Disord 2003;18:1240-9.
75. Bonifati V, Heutink P. Chromosome 1 and Other Hotspots for Parkinson's Disease Genes. In: Kahle P, Haass C, editors. Molecular Mechanisms of Parkinson's disease. 2004;Eurekah.com (freely available in PubMed Bookshelf).
76. Martinez M, Brice A, Vaughan JR, Zimprich A, Breteler MM, Meco G et al. Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease. J Med Genet 2004;41:900-7.
77. Hicks AA, Petursson H, Jonsson T, Stefansson H, Johannsdottir HS, Sainz J et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 2002;52:549-55.
78. Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C et al. Significant linkage of Parkinson disease to chromosome 2q36-37. Am J Hum Genet 2003;72:1053-7.
79. Pankratz N, Nichols WC, Uniacke SK, Halter C, Murrell J, Rudolph A et al. Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. Hum Mol Genet 2003;12:2599-608. Epub 2003 Aug 12.
80. Osaka H, Wang YL, Takada K, Takizawa S, Setsuie R, Li H et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 2003;12:1945-58.
81. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-2.
82. Maraganore DM, Lesnick TG, Elbaz A, Chartier-Harlin MC, Gasser T, Kruger R et al. UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol 2004;55:512-21.
83. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG et al. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 2003;33:85-9.
84. Zimprich A, Asmus F, Leitner P, Castro M, Bereznai B, Homann N et al. Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease. Neurogenetics 2003;4:219-20.
85. Wellenbrock C, Hedrich K, Schafer N, Kasten M, Jacobs H, Schwinger E et al. NR4A2 mutations are rare among European patients with familial Parkinson's disease. Ann Neurol 2003;54:415.
86. Levecque C, Destee A, Mouroux V, Amouyel P, Chartier-Harlin MC. Assessment of Nurr1 nucleotide variations in familial Parkinson's disease. Neurosci Lett 2004;366:135-8.
87. Nichols WC, Uniacke SK, Pankratz N, Reed T, Simon DK, Halter C et al. Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease. Mov Disord 2004;19:649-55.
88. Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ et al. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet 1999;22:110-4.
89. Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H. Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann Neurol 2000;47:521-3.
90. Murray IJ, Medford MA, Guan HP, Rueter SM, Trojanowski JQ, Lee VM. Synphilin in normal human brains and in synucleinopathies: studies with new antibodies. Acta Neuropathol (Berl) 2003;105:177-84.
91. Marx FP, Holzmann C, Strauss KM, Li L, Eberhardt O, Gerhardt E et al. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Hum Mol Genet 2003;12:1223-31.
92. Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC et al. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA 2001;286:2245-50.
93. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 2003;72:804-11.
94. Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 2003;12:3259-67. Epub 2003 Oct 21.
95. van der Walt JM, Noureddine MA, Kittappa R, Hauser MA, Scott WK, McKay R et al. Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am J Hum Genet 2004;74:1121-7. Epub 2004 Apr 30.
96. Healy DG, Abou-Sleiman PM, Ozawa T, Lees AJ, Bhatia K, Ahmadi KR et al. A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease. Ann Neurol 2004;55:443-6.
97. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 2004;351:1972-7.
98. Scherzer CR, Jensen RV, Gullans SR, Feany MB. Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease. Hum Mol Genet 2003:12:2457-66. Epub 2003 Aug 5.
99. Grunblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G et al. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 2004;111:1543-73.